@FierceBiotech: Popular on FierceCRO.com: InVentiv opens U.K. hub as EU demand climbs. Article | Follow @FierceBiotech
@JohnCFierce: The ax drops at troubled Merck as big restructuring gets underway. Story | Follow @JohnCFierce
@DamianFierce: Ex-Calistoga chief Gallagher joins VC Frazier Healthcare to steer biotech bets. News | Follow @DamianFierce
> Glycomimetics says it plans to sell four million shares at a price of $14 to $16 a share. Story
> Cancer Genetics ($CGIX) has closed a public offering of $46 million of shares. Release
> Numab AG says it has reacquired the rights to ND003, a bispecific anti-IL5RxCD3 antibody fragment for the targeted lysis of eosinophils in severe asthma, from Sucampo AG. Release
> Jupiter, FL-based Charleston Laboratories completed its Phase III clinical trial of CL-108 at the midway point after an independent monitoring committee determined that the study should be stopped because both efficacy endpoints of the study have been met. Release
@FierceMedDev: DOD agency commits $70M to develop brain-monitoring implant. Item | Follow @FierceMedDev
@MarkHFierce: Apollo Endosurgery, a 2012 Fierce 15 winner, aims for big growth by snatching up Allergan's obesity device business. Story | Follow @MarkHFierce
@MichaelGFierce: ICYMI: A blog post from the FDA late last week highlighted the agency's efforts to regulate nanotechnology. Blog | Follow @MichaelGFierce
> Edwards slips as so-so outlook leaves investors underwhelmed. Report
> Covidien flips surgical sealants to Integra for $235M. More
Pharma News
@FiercePharma: FDA isn't getting post-marketing data on fast-tracked drugs, per JAMA. Required studies undone or unreported. JAMA report | Follow @FiercePharma
@CarlyHFierce: Biogen's Tecfidera drives rosy Q3 results, higher forecast. ICYMI yesterday | Follow @CarlyHFierce
> Vertex to slash 370 jobs in shift away from hep C drug. News
> Sunk by generics, Pfizer clings to emerging markets, cancer meds. Article
Pharma Manufacturing News
@EricPFierce: What drugs are up for grabs by generic makers next year? Here's the FiercePharma list of 2014 patent losses. | Follow @EricPFierce
> Wockhardt profits crater after U.S., U.K. plant bans. More
> Manufacturing glitch leaves Novo insulin cartridges with bad fills. Report
> Gilead expanding facility that makes highly anticipated hep C drug. Story
> India's plan to inspect China plants stalled. Article
Biotech Research News
@EmilyMFierce: I took a look at 5 promising preclinical drug programs across industry/academia for this latest report. Feature | Follow @EmilyMFierce
> Fast-acting antidepressants discovered. Report
> New obstacle found in search for HIV/AIDS cure. Item
> Certain microRNAs might be viable Alzheimer's targets. Article
> CytomX 'probody' kills pancreatic cancer cells, leaves healthy tissue intact. Story